← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
26	Macquarie Group Sydney, NSW 2000, Australia	$136M	+$140M	3	0.3%	New
27	State Street Boston, Massachusetts	$127M	+$130M	10	0.02%	New
28	Lazard Asset Management New York	$125M	+$129M	1	0.3%	New
29	SSM Sound Shore Management Greenwich, Connecticut	$121M	+$124M	1	2.36%	New
30	Institutional Capital Chicago, Illinois	$121M	+$124M	1	0.62%	New
31	Ameriprise Minneapolis, Minnesota	$119M	+$121M	7	0.08%	New
32	Sterling Capital Management Charlotte, North Carolina	$115M	+$118M	1	1.41%	New
33	Westwood Holdings Group Dallas, Texas	$115M	+$118M	1	1%	New
34	Wellington Management Group Boston, Massachusetts	$115M	+$118M	4	0.04%	New
35	Bahl & Gaynor Cincinnati, Ohio	$115M	+$118M	1	2.17%	New
36	BlackRock Fund Advisors San Francisco, California	$113M	+$115M	8	0.04%	New
37	Ariel Investments Chicago, Illinois	$112M	+$117M	1	1.83%	New
38	BlackRock Institutional Trust San Francisco, California	$110M	+$113M	7	0.02%	New
39	Perceptive Advisors New York	$109M	+$104M	2	11.02%	New
40	John W. Bristol & Co New York	$108M	+$111M	1	1.97%	New
41	JP Morgan Chase New York	$106M	+$109M	5	0.03%	New
42	USSCPF United States Steel & Carnegie Pension Fund New York	$106M	+$109M	1	2.38%	New
43	Credit Suisse Zurich, Switzerland	$104M	+$108M	9	0.11%	New
44	Lord, Abbett & Co Jersey City, New Jersey	$104M	+$98.9M	2	0.24%	New
45	Cambiar Investors Denver, Colorado	$104M	+$106M	1	1.67%	New
46	Capital International Investors Los Angeles, California	$104M	+$106M	1	0.47%	New
47	SCCM Schafer Cullen Capital Management New York	$97.3M	+$100M	2	1.16%	New
48	FC Fairpointe Capital Chicago, Illinois	$94.8M	+$99M	2	1.9%	New
49	Scharf Investments Los Gatos, California	$84.9M	+$87.1M	1	4.6%	New
50	Saturna Capital Bellingham, Washington	$83.6M	+$85.9M	2	2.29%	New